Annual Working Capital
$46.00 M
-$4.69 M-9.26%
31 December 2023
Summary:
Rigel Pharmaceuticals annual working capital is currently $46.00 million, with the most recent change of -$4.69 million (-9.26%) on 31 December 2023. During the last 3 years, it has fallen by -$2.14 million (-4.45%). RIGL annual working capital is now -84.15% below its all-time high of $290.25 million, reached on 31 December 2012.RIGL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$52.16 M
+$16.08 M+44.58%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly working capital is currently $52.16 million, with the most recent change of +$16.08 million (+44.58%) on 30 September 2024. Over the past year, it has increased by +$5.40 million (+11.56%). RIGL quarterly working capital is now -82.03% below its all-time high of $290.25 million, reached on 31 December 2012.RIGL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.3% | +11.6% |
| 3 y3 years | -4.5% | -53.4% |
| 5 y5 years | -57.9% | -45.1% |
RIGL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -49.4% | at low | -53.4% | +170.4% |
| 5 y | 5 years | -57.9% | at low | -64.0% | +170.4% |
| alltime | all time | -84.2% | +4746.4% | -82.0% | +242.2% |
Rigel Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $52.16 M(+44.6%) |
| June 2024 | - | $36.07 M(+87.0%) |
| Mar 2024 | - | $19.29 M(-58.1%) |
| Dec 2023 | $46.00 M(-9.3%) | $46.00 M(-1.6%) |
| Sept 2023 | - | $46.75 M(-17.8%) |
| June 2023 | - | $56.90 M(-7.4%) |
| Mar 2023 | - | $61.45 M(+21.2%) |
| Dec 2022 | $50.69 M(-44.2%) | $50.69 M(-19.8%) |
| Sept 2022 | - | $63.17 M(-3.6%) |
| June 2022 | - | $65.57 M(-17.7%) |
| Mar 2022 | - | $79.71 M(-12.3%) |
| Dec 2021 | $90.91 M(+88.8%) | $90.91 M(-18.7%) |
| Sept 2021 | - | $111.82 M(-10.3%) |
| June 2021 | - | $124.65 M(-13.9%) |
| Mar 2021 | - | $144.74 M(+200.6%) |
| Dec 2020 | $48.14 M(-20.8%) | $48.14 M(-26.7%) |
| Sept 2020 | - | $65.66 M(-16.2%) |
| June 2020 | - | $78.33 M(-8.0%) |
| Mar 2020 | - | $85.16 M(+40.1%) |
| Dec 2019 | $60.79 M(-44.4%) | $60.79 M(-36.0%) |
| Sept 2019 | - | $95.00 M(-1.2%) |
| June 2019 | - | $96.12 M(-15.1%) |
| Mar 2019 | - | $113.18 M(+3.6%) |
| Dec 2018 | $109.25 M(+10.2%) | $109.25 M(+7.8%) |
| Sept 2018 | - | $101.34 M(-16.7%) |
| June 2018 | - | $121.69 M(+56.4%) |
| Mar 2018 | - | $77.83 M(-21.5%) |
| Dec 2017 | $99.10 M(+84.8%) | $99.10 M(+81.6%) |
| Sept 2017 | - | $54.55 M(-19.7%) |
| June 2017 | - | $67.92 M(-17.5%) |
| Mar 2017 | - | $82.28 M(+53.4%) |
| Dec 2016 | $53.63 M(-43.7%) | $53.63 M(-18.6%) |
| Sept 2016 | - | $65.92 M(-12.0%) |
| June 2016 | - | $74.90 M(-3.9%) |
| Mar 2016 | - | $77.89 M(-18.2%) |
| Dec 2015 | $95.23 M(-30.2%) | $95.23 M(-6.0%) |
| Sept 2015 | - | $101.34 M(-9.0%) |
| June 2015 | - | $111.35 M(-13.1%) |
| Mar 2015 | - | $128.17 M(-6.1%) |
| Dec 2014 | $136.51 M(-34.9%) | $136.51 M(-8.2%) |
| Sept 2014 | - | $148.74 M(-11.2%) |
| June 2014 | - | $167.47 M(-11.8%) |
| Mar 2014 | - | $189.96 M(-9.4%) |
| Dec 2013 | $209.78 M(-27.7%) | $209.78 M(-6.6%) |
| Sept 2013 | - | $224.71 M(-8.7%) |
| June 2013 | - | $246.10 M(-7.6%) |
| Mar 2013 | - | $266.25 M(-8.3%) |
| Dec 2012 | $290.25 M | $290.25 M(+64.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $176.04 M(-10.6%) |
| June 2012 | - | $196.87 M(-9.7%) |
| Mar 2012 | - | $218.04 M(-8.7%) |
| Dec 2011 | $238.71 M(+41.6%) | $238.71 M(-8.2%) |
| Sept 2011 | - | $260.17 M(-5.3%) |
| June 2011 | - | $274.78 M(+81.5%) |
| Mar 2011 | - | $151.39 M(-10.2%) |
| Dec 2010 | $168.60 M(+42.6%) | $168.60 M(+31.9%) |
| June 2010 | - | $127.81 M(+31.6%) |
| Mar 2010 | - | $97.14 M(-17.8%) |
| Dec 2009 | $118.19 M(+3.7%) | $118.19 M(-14.9%) |
| Sept 2009 | - | $138.83 M(+120.2%) |
| June 2009 | - | $63.05 M(-28.6%) |
| Mar 2009 | - | $88.30 M(-22.5%) |
| Dec 2008 | $113.94 M(+19.9%) | $113.94 M(-19.2%) |
| Sept 2008 | - | $141.06 M(-18.6%) |
| June 2008 | - | $173.21 M(-14.1%) |
| Mar 2008 | - | $201.69 M(+112.3%) |
| Dec 2007 | $95.02 M(-1.8%) | $95.02 M(-10.9%) |
| Sept 2007 | - | $106.59 M(-12.4%) |
| June 2007 | - | $121.68 M(+46.1%) |
| Mar 2007 | - | $83.28 M(-13.9%) |
| Dec 2006 | $96.78 M(-18.6%) | $96.78 M(-10.5%) |
| Sept 2006 | - | $108.19 M(-4.7%) |
| June 2006 | - | $113.53 M(+0.3%) |
| Mar 2006 | - | $113.21 M(-4.8%) |
| Dec 2005 | $118.95 M(+89.3%) | $118.95 M(+2.1%) |
| Sept 2005 | - | $116.56 M(+140.1%) |
| June 2005 | - | $48.54 M(-20.2%) |
| Mar 2005 | - | $60.81 M(-3.2%) |
| Dec 2004 | $62.82 M(+49.4%) | $62.82 M(-6.4%) |
| Sept 2004 | - | $67.10 M(-14.2%) |
| June 2004 | - | $78.18 M(-13.0%) |
| Mar 2004 | - | $89.90 M(+113.7%) |
| Dec 2003 | $42.06 M(+87.0%) | $42.06 M(-18.2%) |
| Sept 2003 | - | $51.44 M(+0.2%) |
| June 2003 | - | $51.33 M(+236.8%) |
| Mar 2003 | - | $15.24 M(-32.2%) |
| Dec 2002 | $22.49 M(-14.7%) | $22.49 M(-1.7%) |
| Sept 2002 | - | $22.89 M(-37.5%) |
| June 2002 | - | $36.61 M(-23.7%) |
| Mar 2002 | - | $48.00 M(+82.0%) |
| Dec 2001 | $26.37 M(-43.4%) | $26.37 M(-18.4%) |
| Sept 2001 | - | $32.32 M(-11.2%) |
| June 2001 | - | $36.41 M(-12.6%) |
| Mar 2001 | - | $41.65 M(-10.7%) |
| Dec 2000 | $46.63 M(-4809.8%) | $46.63 M |
| Dec 1999 | -$990.00 K | - |
FAQ
- What is Rigel Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual working capital year-on-year change?
- What is Rigel Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly working capital year-on-year change?
What is Rigel Pharmaceuticals annual working capital?
The current annual working capital of RIGL is $46.00 M
What is the all time high annual working capital for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual working capital is $290.25 M
What is Rigel Pharmaceuticals annual working capital year-on-year change?
Over the past year, RIGL annual working capital has changed by -$4.69 M (-9.26%)
What is Rigel Pharmaceuticals quarterly working capital?
The current quarterly working capital of RIGL is $52.16 M
What is the all time high quarterly working capital for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly working capital is $290.25 M
What is Rigel Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, RIGL quarterly working capital has changed by +$5.40 M (+11.56%)